Insights on the Global Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market to 2024 –

DUBLIN–()–The “Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market” report has been added to’s offering.

Global sales of neuromodulation systems for the treatment of movement disorders (Parkinson’s disease, essential tremor, and dystonia) and epilepsy, which include implantable deep brain stimulation (DBS) and vagus nerve stimulation (VNS) devices, respectively, are expected to increase at a CAGR of approximately 8.5%, from nearly $1.2bn in 2019 to approximately $1.8bn in 2024.

The highly competitive DBS and VNS segments – which contribute nearly one-third of the global $4.5bn+ neuromodulation market – are significantly underpenetrated, with substantial room for growth. The DBS/VNS markets are being driven by several positive factors, including: a long clinical history with a substantial reduction in debilitating symptoms, strong marketing and surgeon training efforts, and technological innovation (eg new directional lead technologies, precisely targeted stimulation, and therapy customization). The launch of next-generation DBS and VNS systems are further improving outcomes and providing patients with incurable neurological conditions a safe, effective, and long-term device-based therapy alternative.

The report provides the following useful information:

  • An overview of neuromodulation technology for the treatment of refractory neurological movement disorders and epilepsy
  • Key epidemiology data on the prevalence of Parkinson’s disease, essential tremor, dystonia, epilepsy, and depression
  • Related product portfolios offered by leading manufacturers
  • Top selling neuromodulation devices, as well as emerging products under development
  • In-depth market and competitive analyses.

Key Topics Covered:

1. Clinical Overview

1.1 Deep brain stimulation

1.2 Vagus nerve stimulation

1.3 Movement disorders

1.3.1 Parkinson’s disease

1.3.2 Essential tremor

1.3.3 Dystonia

1.4 Epilepsy

1.5 Major depressive disorder

1.6 Prevalence of neurological disorders

1.7 Bibliography

2. Deep Brain Stimulation Technology

2.1 Selected products

2.1.1 Abbott

2.1.2 Boston Scientific

2.1.3 Medtronic

2.2 Bibliography

3. Vagus Nerve Stimulation Technology

3.1 Selected products

3.1.1 LivaNova

3.1.2 Medtronic

3.1.3 NeuroPace

3.2 Bibliography

4. Market Analysis

4.1 Deep brain stimulation devices market

4.1.1 Market forecast: global

4.1.2 Market forecast: by region

4.1.3 Market drivers and limiters

4.1.4 Market share: global

4.1.5 Market share: by region

4.2 Vagus nerve stimulation devices market

4.2.1 Market forecast: global

4.2.2 Market forecast: by region

4.2.3 Market drivers and limiters

4.2.4 Market share: global

4.2.5 Market share: by region

4.3 Combined market

4.4 Corporate profiles

4.4.1 Abbott

4.4.2 Boston Scientific

4.4.3 LivaNova

4.4.4 Medtronic

4.5 Bibliography

Companies Mentioned

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • NeuroPace

For more information about this report visit


About the Author: Biotech Today

You might like